STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs

With the emergence of recent landmark trials, the treatment for hormone-sensitive metastatic prostate cancer (hsMPC) is changing from androgen deprivation therapy (ADT) alone to combination therapy. Both, docetaxel chemotherapy and abiraterone in addition to ADT have been extensively studied in well...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Indian J Urol
Asıl Yazarlar: Sharma, Aditya Prakash, Mavuduru, Ravimohan S., Bora, Girdhar Singh, Devana, Sudheer K, Singh, Shrawan K., Mandal, Arup K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2018
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034411/
https://ncbi.nlm.nih.gov/pubmed/30034127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/iju.IJU_378_17
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller